gene 953 words KG: LGALS3 2026-03-24
kind:genesection:genesstate:published
Contents

LGALS3 Gene

🧬 Gene Info
Gene SymbolLGALS3
Full NameLectin, Galactoside-Binding, Soluble, 3
Chromosome14
FunctionThe LGALS3 gene encodes Lectin, Galactoside-Binding, Soluble, 3, a protein expressed in various brain regions including the cerebral cortex, hippocampus, basal ganglia, and cerebellum.
Primary Expressionactivated microglia and plays complex roles in neuroinflammation - both promoting and resolving inflammatory responses
PathwaysAmyloid, Lipid Metabolism
UniProt IDP17931
Ensembl IDENSG00000131981
OMIM153619
GeneCardsLGALS3
Human Protein AtlasLGALS3
Genomic Location14q22.3
ApproachStatus
Small molecule inhibitorsPreclinical
Monoclonal antibodiesPreclinical
Associated DiseasesAD, ALI, ALS, Alzheimer, Amyotrophic Lateral Sclerosis
Known Drugs/Compoundsrapamycin
InteractionsCALCOCO2, G3BP1, PEX3, SQSTM1, BCL2, LMNA
KG Connections952 knowledge graph edges
DatabasesGeneCardsNCBI GeneHPASTRING

Knowledge Graph

Related Hypotheses (30)

Liquid-Liquid Phase Separation Modifier Therapy
Score: 0.42
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
CYP46A1 Overexpression Gene Therapy
Score: 0.63
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56

Related Analyses (8)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed

Related Experiments (22)

s:** - Single-cell RNA-seq to measure editing efficiency acr
falsification · proposed · Score: 0.40
Metabolic Pathway-Targeted Therapy in ALS
clinical · proposed · Score: 0.40
ALS Progression Rate Heterogeneity — mechanism and biomarker
clinical · proposed · Score: 0.40
ALS Regional Onset and Spread: Network-Level Staging Model
clinical · proposed · Score: 0.40
Sporadic ALS Initiation Biology: Deep Phenotyping of At-Risk
clinical · proposed · Score: 0.40

See Also (9)

Aging vs Neurodegeneration: Mechanistic Comparison Matr
mechanism · KG edge: therapeutic_target
Actin Cytoskeleton Dynamics in Neurodegeneration
mechanism · KG edge: co_discussed
Packard Center for ALS Research
institution · KG edge: activates
Accelerating Medicines Partnership for Alzheimer's Dise
institution · KG edge: implicated_in
Alzheimer Indonesia
institution · KG edge: activates

Knowledge Graph (12 edges)

LGALS3 interacts_with CALCOCO2
LGALS3 interacts_with G3BP1
LGALS3 interacts_with PEX3
LGALS3 interacts_with SQSTM1
LGALS3 interacts_with BCL2
LGALS3 interacts_with LMNA
LGALS3 interacts_with STING1
LGALS3 interacts_with TAX1BP1
LGALS3 interacts_with ATM
LGALS3 interacts_with SNCAIP